1 unchanged sentence
On May 3, 2023, our Board of Directors terminated the previous share repurchase program then in effect and authorized a new share repurchase program for the purchase of up to $500 million (net of taxes, fees and commissions).
−Removed: This share repurchase program has no specified expiration date.
−Removed: Under the May 3, 2023 authorization, the Company may repurchase its shares from time to time through open market purchases, including 10b5-1 plans.
+Added: As of June 30, 2024, there was $444 million (net of taxes, fees and commissions) of remaining availability under the Board authorized share repurchase program.
+Added: The share repurchase program has no specified expiration date.
+Added: Under the May 3, 2023 share repurchase program, the Company may repurchase its shares from time to time through open market purchases, including 10b5-1 plans.
Any share repurchases may be activated, suspended or discontinued at any time.
−Removed: During the first nine months of fiscal 2024, we had no share repurchase activity pursuant to the previous share repurchase program or the May 3, 2023 authorization.
−Removed: This does not include 7 shares purchased during the quarter at an average price of $209.09 per share by the STERIS Corporation 401(k) Plan on behalf of an executive officer of the Company who may be deemed to be an affiliated purchaser.
−Removed: During the first nine months of fiscal 2024, we obtained 69,276 of our ordinary shares in the aggregate amount of $11.4 million in connection with share-based compensation award programs.
−Removed: The following table summarizes the ordinary shares repurchase activity during the third quarter of fiscal 2024 under our ordinary share repurchase program:
+Added: During the first three months of fiscal 2025, we repurchased 251,507 of our ordinary shares for the aggregate amount of $56.1 million (net of fees and commissions) pursuant to authorizations under the share repurchase program.
+Added: During the first three months of fiscal 2025, we obtained 69,780 of our ordinary shares in the aggregate amount of $10.3 million in connection with share-based compensation award programs.
+Added: The following table summarizes the ordinary shares repurchase activity during the first quarter of fiscal 2025 under our ordinary share repurchase program:
(dollars in thousands)
8 unchanged sentences
Plans at Period End (in thousands)
−Removed: October 1-31 — $ — — $ 500,000
−Removed: November 1-30 — — — 500,000
−Removed: December 1-31 — — — 500,000
+Added: April 1-30 — $ — — $ 500,000
+Added: May 1-31 90,000 228.01 90,000 479,479
+Added: June 1-30 161,507 220.44 161,507 443,876
Total 251,507 (1) $ 223.15 (1) 251,507 $ 443,876
+Added: (1) Does not include 9 shares purchased during the quarter at an average price of $217.93 per share by the STERIS Corporation 401(k) Plan on behalf of an executive officer of the Company who may be deemed to be an affiliated purchaser.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.